Author:
Hilleman Daniel E.,Vacek James L.,Backes James M.
Publisher
Southern Medical Association
Reference50 articles.
1. Use of lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association;J Clin Lipidol
2. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease. A scientific statement from the American Heart Association;Arterioscler Thromb Vasc Biol
3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Circulation
4. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS);Eur Heart J
5. Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider;Eur J Prev Cardiol